🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Resectable Colon Cancer

Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3 NCT07595874Phase 211 sites📍 Goodyear📍 Corona📍 Duarte City of Hope Medical Center · Tests: Balstilimab, Biospecimen Collection, Botensilimab, Computed Tomography, Magnetic Resonance Imaging Study to Evaluate the Efficacy and Safety of Cetuximab in Combination with Encorafenib Plus Binimetinib As Induction Treatment in BRAF V600E Mutated MSS Initially Resectable or Potentially Resectable Advanced Colorectal Cancer NCT06207656Phase 21 site📍 Madrid Spanish Cooperative Group for the Treatment of Digestive Tu… · Tests: EBC Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease NCT07750158Phase 313 sites📍 Council Bluffs📍 Grand Island📍 Grand Island Exelixis · Tests: Zanzalintinib, Pembrolizumab (+) Berahyaluronidase alfa, Placebo Conversion From Unresectable To Resectable Metastatic Colorectal Cancer. NCT03401294Phase 21 site📍 Regina University of Saskatchewan · Tests: FOLFOXIRI and Bevacizumab Perioperative Versus Postoperative CapOX Chemotherapy for Locally Advanced Colon Cancer NCT03125980Phase 31 site📍 Shanghai Fudan University · Tests: capecitabine plus oxaliplatin before and after surgery, capecitabine plus oxaliplatin after surgery Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform NCT06349642n/a3 sites📍 Phoenix📍 Jacksonville📍 Rochester Mayo Clinic · Tests: Biospecimen Collection, Tissue Collection MRD-guided Deferred Adjuvant Therapy in Resectable Early-stage Colon Cancer NCT06204484NA1 site📍 Guangzhou Sun Yat-sen University · Tests: CAPEOX adjuvant therapy, deferred CAPEOX adjuvant therapy, mFOLFOXIRI intensive adjuvant therapy Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer NCT05855200Phase 3266 sites📍 Tucson📍 Los Angeles📍 New Haven GlaxoSmithKline · Tests: Dostarlimab, CAPEOX, FOLFOX Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN) NCT05845450Phase 21 site📍 Milan Gruppo Oncologico del Nord-Ovest · Tests: Trastuzumab deruxtecan, Durvalumab, Panitumumab, Botensilimab, Balstilimab Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA NCT05797077Phase 31 site📍 Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University · Tests: Colorectal resection surgery., FOLFOX chemotherapy regimen, Capecitabine A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer NCT06686576Phase 31 site📍 Guangzhou Qilu Pharmaceutical Co., Ltd. · Tests: QL1706, CAPEOX/Capecitabine Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery NCT06731998NA1 site📍 Pittsburgh Allegheny Singer Research Institute (also known as Alleghen… · Tests: Local Anesthesia, Laparoscopic Transversus Abdominis Plane block Intravital Microscopy in Human Solid Tumors NCT03823144NA1 site📍 Jacksonville Mayo Clinic · Tests: Diagnostic Microscopy, Fluorescein Sodium Injection Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER NCT05870800Phase 21 site📍 Houston Baylor College of Medicine · Tests: Tecentriq 1200 MG in 20 ML Injection + Capecitabine 1000 mg/m2 + Oxaliplatin 130 mg/m2, Oxaliplatin injection 85mg/m2 +… Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers NCT05194878Phase 31 site📍 Guangzhou Sun Yat-sen University · Tests: neoadjuvant chemotherapyI, Colectomy, adjuvant chemotherapy Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases NCT02172651EARLY Phase 11 site📍 Boston Dana-Farber Cancer Institute · Tests: Vitamin D3, Placebo An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response NCT04796818NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Diffusion Weighted Imaging In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung NCT05611034Phase 11 site📍 Toronto University Health Network, Toronto · Tests: Oxaliplatin A Single-Arm, Phase II, Multicenter Clinical Study of Neoadjuvant Encorafenib Plus Cetuximab N01 and mFOLFOX6 in Patients With Locally Advanced BRAF V600E-Mutant Colorectal Cancer With or Without Resectable Metastases NCT07789210Phase 21 site📍 Hangzhou Zhejiang University · Tests: Neoadjuvant therapy of encorafenib plus cetuximab N01 and mFOLFOX6 Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients NCT07125729NA13 sites📍 Goodyear📍 Corona📍 Duarte City of Hope Medical Center · Tests: Biospecimen Collection, cfDNA or ctDNA Measurement, Electronic Health Record Review CT-95 in Advanced Cancers Associated With Mesothelin Expression NCT06756035Phase 19 sites📍 Denver📍 Chicago📍 Grand Rapids Context Therapeutics Inc. · Tests: CT-95 Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients NCT06280495Phase 2, Phase 31 site📍 Guangzhou Sun Yat-sen University · Tests: Oxaliplatin, Fluorouracil, Serplulimab, Bevacizumab Neoadjuvant Treatment of Fulzerasib Plus Cetuximab N01 in KRAS G12C Mutated Locally Advanced Colorectal Cancer With or Without Resectable Metastases NCT07581912Phase 21 site📍 Hangzhou Zhejiang University · Tests: fulzerasib; cetuximab N01 Liver Transplantation for Non-resectable Colorectal Liver Metastases: Translational Research NCT05398380NA1 site📍 Barcelona Hospital Vall d'Hebron · Tests: Liver transplantation Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases NCT07277322Phase 1, Phase 21 site📍 New York Dan Feng · Tests: Dupilumab, Toripalimab Postoperative Circulating Tumor DNA Monitoring in Stage I-III Driver-Mutant Colon Adenocarcinoma NCT07795528n/a1 site📍 Shanghai Ruijin Hospital · Tests: Longitudinal ctDNA-MRD NGS testing at scheduled postoperative time points LDLT in Non Resectable Colo-rectal Cancer Liver Metastasis NCT05186116NA1 site📍 Modena Azienda Ospedaliero-Universitaria di Modena · Tests: Living donor liver transplant, Split liver transplant, RAPID, DDLT Liver Transplantation for Non-Resectable Colorectal Liver Metastasis NCT05185245NA1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: Liver Transplantation Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer NCT07808151Phase 230 sites📍 Los Angeles📍 Tampa📍 Chicago Solstice Oncology, Inc. · Tests: Pembrolizumab, Porustobart Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer NCT07412613Phase 31 site📍 Guangzhou Akeso · Tests: Cadonilimab (AK104), Oxaliplatin, Capecitabine, 5- Fluorouracil, Calcium Folinate
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy